IT1317001B1 - USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS. - Google Patents

USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Info

Publication number
IT1317001B1
IT1317001B1 IT2000RM000129A ITRM20000129A IT1317001B1 IT 1317001 B1 IT1317001 B1 IT 1317001B1 IT 2000RM000129 A IT2000RM000129 A IT 2000RM000129A IT RM20000129 A ITRM20000129 A IT RM20000129A IT 1317001 B1 IT1317001 B1 IT 1317001B1
Authority
IT
Italy
Prior art keywords
spirolaxin
treatment
pathologies associated
altered angiogenesis
angiogenesis
Prior art date
Application number
IT2000RM000129A
Other languages
Italian (it)
Inventor
Sergio Penco
Claudio Pisano
Giuseppe Giannini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2000RM000129A priority Critical patent/IT1317001B1/en
Publication of ITRM20000129A0 publication Critical patent/ITRM20000129A0/en
Priority to AU44533/01A priority patent/AU4453301A/en
Priority to PCT/IT2001/000113 priority patent/WO2001068070A2/en
Publication of ITRM20000129A1 publication Critical patent/ITRM20000129A1/en
Application granted granted Critical
Publication of IT1317001B1 publication Critical patent/IT1317001B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IT2000RM000129A 2000-03-13 2000-03-13 USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS. IT1317001B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000RM000129A IT1317001B1 (en) 2000-03-13 2000-03-13 USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.
AU44533/01A AU4453301A (en) 2000-03-13 2001-03-07 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
PCT/IT2001/000113 WO2001068070A2 (en) 2000-03-13 2001-03-07 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000129A IT1317001B1 (en) 2000-03-13 2000-03-13 USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Publications (3)

Publication Number Publication Date
ITRM20000129A0 ITRM20000129A0 (en) 2000-03-13
ITRM20000129A1 ITRM20000129A1 (en) 2001-09-13
IT1317001B1 true IT1317001B1 (en) 2003-05-26

Family

ID=11454527

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000129A IT1317001B1 (en) 2000-03-13 2000-03-13 USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Country Status (3)

Country Link
AU (1) AU4453301A (en)
IT (1) IT1317001B1 (en)
WO (1) WO2001068070A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010136A1 (en) * 2001-03-16 2002-09-16 Sigma Tau Ind Farmaceuti USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF THE PPAR-GAMMA RECEPTOR.
ITMI20041279A1 (en) * 2004-06-24 2004-09-24 Pharmaproducts Uk Ltd USE OF TRIFLUOROACETATE CALCIUM FOR THE PREPARATION OF ANTI-ANGIOGENETIC EFFECT MEDICATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005204A1 (en) * 1994-08-09 1996-02-22 Pfizer Inc. Spirolaxine derivatives for treating gastroduodenal diseases
JPH107557A (en) * 1996-06-17 1998-01-13 Banyu Pharmaceut Co Ltd Antitumor substance spirolaxine
AU751283B2 (en) * 1998-07-14 2002-08-08 Bristol-Myers Squibb Company Lysine binding fragments of angiostatin

Also Published As

Publication number Publication date
WO2001068070A2 (en) 2001-09-20
AU4453301A (en) 2001-09-24
ITRM20000129A1 (en) 2001-09-13
ITRM20000129A0 (en) 2000-03-13
WO2001068070A3 (en) 2002-04-18
WO2001068070A8 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
DE50112057D1 (en) Cleaning-friendly glass ceramic body
FI20001914A0 (en) The electrode structure
ZA200107111B (en) Ceramic structure.
NL1017973A1 (en) Design.
NL1019181A1 (en) Stabilized metallocene-polypropylene.
BR0008833B1 (en) Built plunger.
IT249776Y1 (en) MONOLITHIC THROUGH INSULATOR
IT1317001B1 (en) USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.
ATE278659T1 (en) O-DESMETHYLVENLAFAXIN ETHER
ITTO20011197A0 (en) ORNAMENTAL CYLINDRICAL BODY.
IT1317869B1 (en) SHOWER.
ITAR990019V0 (en) DRAWN DRAWING WITH CODULO.
ES1048246Y (en) CERAMIC PIECE.
IT246402Y1 (en) THE MATTRESS OF THE REST.
FIU20000034U0 (en) The tune-changing mechanism of the kantele
IT1320746B1 (en) GO UP THE CHANDELIER.
IT249404Y1 (en) CHAIR STRUCTURE.
IT1318461B1 (en) EXTENDABLE TABLE.
ITGE990120A1 (en) CUP WITH TOWEL.
ITRM20000040U1 (en) EASY PLAYNET.
ES1049547Y (en) IMPROVED SUPPORT STRUCTURE.
ITMI20001600A0 (en) PROCEDURE FOR THE PREPARATION OF 5-AMINO-4-ALO-3-ALKYL ISOXAZOLES.
ES1050534Y (en) TOILET WITH BRUSH INCORPORATED.
IT1311539B1 (en) EXTENDABLE TABLE.
IT1320253B1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MALARIA.